These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4136749)

  • 1. Genitourinary-tract problems of the aged male.
    Basso A
    J Am Geriatr Soc; 1974 Aug; 22(8):352-4. PubMed ID: 4136749
    [No Abstract]   [Full Text] [Related]  

  • 2. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 3. [Predictive value of clinical, biochemical, hormonal and histologic parameters of the endocrine response in prostatic adenocarcinoma].
    Burgos FJ; Maganto E; Jiménez M; Mayayo T; Allona A; Mateos A; Escudero A; Romero-Aguirre C
    Actas Urol Esp; 1988; 12(6):500-6. PubMed ID: 3232555
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenocarcinoma of the prostate.
    Von Eschenbach AC; Johnson DE
    Compr Ther; 1978 Aug; 4(8):18-26. PubMed ID: 688739
    [No Abstract]   [Full Text] [Related]  

  • 5. Current concepts concerning carcinoma of the prostate.
    Skinner DG
    Surg Annu; 1973; 5():393-406. PubMed ID: 4602222
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging.
    Gleason DF; Mellinger GT;
    J Urol; 2017 Feb; 197(2S):S134-S139. PubMed ID: 28012760
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostatic cancer with bone marrow involvement and long-term survival: association with intravenous chemotherapy.
    Boatman DL; Nelson CM; Flocks RH; Schmidt JD
    J Surg Oncol; 1973 May; 5(5):481-4. PubMed ID: 4752465
    [No Abstract]   [Full Text] [Related]  

  • 8. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402
    [No Abstract]   [Full Text] [Related]  

  • 9. Origins of prostate cancer.
    Montironi R; Bostwick DG; Bonkhoff H; Cockett AT; Helpap B; Troncoso P; Waters D
    Cancer; 1996 Jul; 78(2):362-5. PubMed ID: 8674018
    [No Abstract]   [Full Text] [Related]  

  • 10. An unusual remission of prostatic carcinoma with pulmonary metastases.
    Stenberg CC; Bunts RC
    J Urol; 1969 Aug; 102(2):236-9. PubMed ID: 5796902
    [No Abstract]   [Full Text] [Related]  

  • 11. Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
    de Voogt HJ; Suciu S; Sylvester R; Pavone-Macaluso M; Smith PH; de Pauw M
    J Urol; 1989 Apr; 141(4):883-8. PubMed ID: 2522561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF; Mellinger GT
    J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of prostatic cancer.
    Schmidt JD
    Urol Clin North Am; 1975 Feb; 2(1):185-96. PubMed ID: 1093059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further experience with the Franzen transrectal prostatic biopsy needle.
    Ward JP
    Ann Chir Gynaecol Fenn; 1974; 63(1):48-52. PubMed ID: 4134053
    [No Abstract]   [Full Text] [Related]  

  • 15. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosis of prostatic carcinoma.
    Mellinger GT
    Recent Results Cancer Res; 1977; (60):61-72. PubMed ID: 866797
    [No Abstract]   [Full Text] [Related]  

  • 17. An aggressive approach to prostatic cancer.
    Alyea EP; Dees JE; Glenn JF
    J Urol; 1977 Jul; 118(1 Pt 2):211-5. PubMed ID: 327106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonal treatment of cancer of the prostate].
    Aguiló F; Torrecilla C; Muñoz J; Tesedo X; Vigués F; Serrallach N
    Actas Urol Esp; 1989; 13(4):256-63. PubMed ID: 2678937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prelinimary report on combination therapy for advanced prostatic cancer.
    Merrin C
    Cancer Treat Rep; 1977; 61(2):313-5. PubMed ID: 559544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.